CD86 and B-cell non-Hodgkin lymphoma: Likewise, CD40L gene transfer in B-cell lymphoma cells from patients resulted in enhanced expression of CD80 and CD86 [32] and generation of tumor-specific T-cell response in vitro [32, 33].